Arterioscler Thromb Vasc Biol

Slides:

Advertisements

Similar presentations

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.

Advertisements

Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions Statins0.69 ( ) n=13 (16,228/11,279)

Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External DefibrillatorsCLINICAL PERSPECTIVE by Marieke T. Blom, Stefanie G.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):

Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules by Martijn A.W. Broeders, Geert Jan Tangelder, Dick W. Slaaf, Robert S. Reneman,

Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?Clinical Perspective by Peter J. Schwartz,

Volume 149, Issue 5, Pages (May 2016)

The relationship between maintenance dosages of three vitamin K antagonists: Acenocoumarol, warfarin and phenprocoumon Yvonne van Leeuwen, Frits R. Rosendaal,

Volume 136, Issue 1, Pages (July 2015)

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction by Jordi Matías-Guiu, José M. Ferro, José Alvarez-Sabín,

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

Calcification burden of the femoropopliteal artery demonstrating progression from a healthy artery with no calcification (0) to advanced calcific deposits.

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

Regulation of Hypoxia-Inducible Genes by PGC-1α

New LINE(s) of Evidence for Genetic Regulation of Platelets

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

by Jenny K. Rinehart, Rena D. Singleton, John C. Adair, Joseph R

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke by Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Yu-Chun Chen, Tzeng-Ji.

Arterioscler Thromb Vasc Biol

Assessment of Unstable Atherosclerosis in Mice

Site Selection and Performance in Clinical Trials

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,

Contribution of Stroke to the Cochrane Stroke Group Trials Register

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol

Reflux Esophagitis and the Risk of Stroke in Young Adults

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,

by Hugoline G. de Haan, Irene D. Bezemer, Carine J. M

Arterioscler Thromb Vasc Biol

Infusion of CSL112 increases total cholesterol efflux capacity (CEC) regardless of baseline functional apolipoprotein A-I (apoA-I) activity. Infusion of.

Arterioscler Thromb Vasc Biol

HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis

Arterioscler Thromb Vasc Biol

The Process of Rehabilitation and Discharge Planning in Stroke

by Karen Reue, Robert D. Cohen, and Michael C. Schotz

Arterioscler Thromb Vasc Biol

by Ariella Zivelin, John H

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk.

(A) The stratified analysis for DFS because of the uncertain status of HER2, 132 patients could be calculated the recurrence risk score. (A) The stratified.

Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S by Michael Makris, Michael Leach,

Jenna Barton, MSN, RN-C, PCCN

Presentation transcript:

Arterioscler Thromb Vasc Biol Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia by Carla Y. Vossen, Isobel D. Walker, Peter Svensson, Juan C. Souto, Inge Scharrer, F. Eric Preston, Gualtiero Palareti, Ingrid Pabinger, Felix J.M. van der Meer, Mike Makris, Jordi Fontcuberta, Jacqueline Conard, and Frits R. Rosendaal Arterioscler Thromb Vasc Biol Volume 25(9):1992-1997 September 1, 2005 Copyright © American Heart Association, Inc. All rights reserved.

Percentage of individuals who were free of a recurrent venous event according to the number of years after a first event (calculated using the Kurtzke method). Percentage of individuals who were free of a recurrent venous event according to the number of years after a first event (calculated using the Kurtzke method). Carla Y. Vossen et al. Arterioscler Thromb Vasc Biol. 2005;25:1992-1997 Copyright © American Heart Association, Inc. All rights reserved.